Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 4 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 1 (10%) |
| §102 only | 1 (10%) |
| Double-patenting + other | 5 (50%) |
| Multi-statute (no §101) | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, DAWANNA SHAR-DAY | 2 | 62.5% | +23.3% |
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.6% | +53.8% |
| PIHONAK, SARAH | 1 | 61.3% | +42.6% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| SZNAIDMAN, MARCOS L | 1 | 37.3% | +16.2% |
| TATGE, LEXUS MARC | 1 | 50.0% | +100.0% |
| KUCKLA, ANNA GRACE | 1 | 53.2% | +54.1% |
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
| SAEED, KAMAL A | 1 | 83.9% | +9.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18565752 | METHODS OF SLOWING AN INCREASE IN BRAIN VENTRICULAR VOLUME | SAEED, KAMAL A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18527638 | TREATMENT OF ACUTE ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR | KUCKLA, ANNA GRACE | 5d overdue |
| 18839564 | TRICHOSTATIN A (TSA) SENSITIVITY IN THE TREATMENT OF TUMORS | WHITE, DAWANNA SHAR-DAY | — |
| 18565690 | METHODS FOR TREATING MULTIPLE SCLEROSIS | GONZALEZ, LUISALBERTO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18527638 | TREATMENT OF ACUTE ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR | KUCKLA, ANNA GRACE | 5d overdue |
| 18249920 | TREATMENT OF PUBLIC SPEAKING ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST | WHITE, DAWANNA SHAR-DAY | 27d |
| 18839564 | TRICHOSTATIN A (TSA) SENSITIVITY IN THE TREATMENT OF TUMORS | WHITE, DAWANNA SHAR-DAY | — |
| 18754070 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | RAMACHANDRAN, UMAMAHESWARI | — |
| 18652776 | USE OF TRADIPITANT IN MOTION SICKNESS | PIHONAK, SARAH | — |
| 18611987 | TREATMENT OF DISORDERS WITH TASIMELTEON | RODRIGUEZ, RAYNA B | — |
| 18691426 | TREATMENT OF SLEEP DISTRUBANCES IN AUTISM SPECTRUM DISORDER PATIENTS | SZNAIDMAN, MARCOS L | — |
| 18578371 | Antisense Oligonucleotide (ASO) Gene Inhibition and Treatment | TATGE, LEXUS MARC | — |
| Art Unit | Apps |
|---|---|
| 1627 | 3 |
| 1626 | 2 |
| 1628 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18839564 | TRICHOSTATIN A (TSA) SENSITIVITY IN THE TREATMENT OF TUMORS | WHITE, DAWANNA SHAR-DAY | — | §101§103DP | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18754070 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | RAMACHANDRAN, UMAMAHESWARI | 1627 | §112DP | Non-Final OA | — | Pending | Jun 25, 2024 |
| 18652776 | USE OF TRADIPITANT IN MOTION SICKNESS | PIHONAK, SARAH | 1627 | §103DP | Non-Final OA | — | Pending | May 01, 2024 |
| 18611987 | TREATMENT OF DISORDERS WITH TASIMELTEON | RODRIGUEZ, RAYNA B | — | §102§103DP | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18691426 | TREATMENT OF SLEEP DISTRUBANCES IN AUTISM SPECTRUM DISORDER PATIENTS | SZNAIDMAN, MARCOS L | 1628 | §103 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18578371 | Antisense Oligonucleotide (ASO) Gene Inhibition and Treatment | TATGE, LEXUS MARC | — | §103DP | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18527638 | TREATMENT OF ACUTE ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR | KUCKLA, ANNA GRACE | 1626 | §102§103Other | Final Rejection | 5d overdue | Pending | Dec 04, 2023 |
| 18565690 | METHODS FOR TREATING MULTIPLE SCLEROSIS | GONZALEZ, LUISALBERTO | 1624 | §102§103 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18565752 | METHODS OF SLOWING AN INCREASE IN BRAIN VENTRICULAR VOLUME | SAEED, KAMAL A | 1626 | §102 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18249920 | TREATMENT OF PUBLIC SPEAKING ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST | WHITE, DAWANNA SHAR-DAY | 1627 | §103DP | Final Rejection | 27d | Pending | Oct 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial